A prospective observational study of the effectiveness, safety, and effect on fatigue of darbepoetin alfa for the treatment of chemotherapy-induced anaemia Mel JR, Salar A, Rodríguez CA, Alegre A, González A, Cassinello J,Montesinos J, Gasquet JA, Sánchez J, Saigí E. AMG-DAR-2002-01 Study Group Current Medical Research and Opinion 24(10):2931-42. FI: 2.498 (Q1) JA Patients' perception of cancer-related fatigue: results of a survey to assess the impact on their everyday life Díaz N, Menjón S, Rolfo C, García-Alonso P, Carulla J, Magro A, Miramón J,Rodríguez CA, de Castellar R, Gasquet JA. Clinical & Translational Oncology 10(11):753-7. FI: 1.146 (Q4) An epidemiological study of the perception of asthenia by oncologists in cancer patients: POA study González Barón M, Feijóo M, Escobar Alvarez Y. ASTHENOS Group Clinical & Translational Oncology 10(5):288-93. FI: 1.146 (Q4) Development of a new measure to assess patient perceptions about cancer-related fatigue: item generation and item reduction Baró E, Carulla J, Cassinello J, Colomer R, García Mata J, Gascón P, Herdman M, Gasquet JA, Rodríguez C, Sánchez J,Valentín V. Value in Health 12: 130-138. FI: 3.032 (Q1) Gemcitabine and capecitabine in previously anthracycline-treated metastatic breast cancer. A multicenter phase II study (solti 0301 trial) Ciruelos EM, Cortés J, Cortés-Funes H, Mayordomo JI, Bermejo B, Ojeda B, García E, Rodríguez CA, Muñoz M, Gómez P, Manso L, Andrés R, Lluch A, Saura C, Mendiola C, Baselga J. Annals of Oncology 21(7):1442. FI: 5.647 (Q1) Supportive care for patients with early breast cancer García-Estévez L, Tusquets I, Alvarez I, Rodríguez C, Fernández Y, Seguí MA, García-Mata J, Lluch A. Clinical & Translational Oncology 12(1): 32-42. FI: 1.146 (Q4) Phase II study of Capecitabine as palliative treatment for patients with recurrent and metastatic squamous head and neck cancer after previous platinum-based treatment Martinez-Trufero J, Isla D, Adansa JC, Irigoyen A, Hitt R, Gil-Arnaiz I, Lambea J, Lecumberri MJ, Cruz JJ. British Journal of Cancer 102 (12): 1687-91. FI: 4.346 (Q1) An Overview of Letrozole in Postmenopausal Women with Hormone-Responsive Breast Cancer Agusti Barnadas; Laura G. Estevez; Ana Lluch-Hernandez; Alvaro Rodriguez-Lescure; César A. Rodríguez Sánchez; Pedro Sanchez-Rovira Advances In Therapy 28: 1045-1058. FI: 1,668(Q3) SEOM clinical guidelines for the treatment of thyroid cancer Javier Martinez Trufero; Jaume Capdevilla; Juan Jesús Cruz Hernández; Dolores Isla Clinical & Translational Oncology 13: 574-579. FI: 1,254(Q4) Breakthrough cancer pain - still a challenge. Margarit C; Juliá J; López R; Anton A; Escobar Y; Casas A; Cruz JJ; Galvez R; Mañas A; Zaragozá F Journal Of Pain Research. 5: 559-566
|
